Climb Bio

IPO

Inspired Medicines for Immune-Mediated Diseases

Climb Bio is a biotech company in Wellesley Hills, United States, founded in 2018. It has raised $170.0M across 2 rounds, most recently a $110.0M Private Equity in April 2026.

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$170.0M
Last Round
$110.0M Private EquityApr 2026
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. to use credits for reveals, or explore the API.

About

Climb Bio is a clinical-stage biotechnology company whose mission is to deliver high-impact, disease-modifying medicines for people living with immune-mediated diseases. The company develops differentiated monoclonal antibody therapies and is advancing several investigational programs through clinical trials across multiple disease areas, aiming to give patients with limited therapeutic options more quality time and less time defined by illness. Climb Bio is headquartered in Wellesley Hills, Massachusetts.

Funding History

Data from Indexed.vcUpdated
Private EquityPrivate EquityApr 2026
$110.0M

1 more funding event

  • Series B20233 investors

Funding: Series B through Private Equity. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×2
  • Cloud/Infrastructure ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Climb Bio on Indexed.vc
<a href="https://indexed.vc/companies/climb-bio"><img src="https://indexed.vc/api/badge/company/climb-bio" alt="Climb Bio on Indexed.vc" width="260" height="76" /></a>